ver (11.1%), fatigue (11.1%), myalgia (9.2%), and gastrointestinal symptoms (7.5%) [32]. In a study of 23 MERS patients from South Korea, 17.4% experienced neurological symptoms either during or following MERS treatment [33]. These neurological complications occurred about two to three weeks after the onset of respiratory symptoms [33]. A study